ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Angelini Fine Chemicals Invests in Flow Chemistry & Micro-Reaction Technology
May 13, 2021A confluence of factors is driving the need for a paradigm shift in pharmaceutical manufacturing strategies in order to accelerate R&D pipeline to market. -
EC approval for Ontozry
April 07, 2021Angelini Pharma has announced European Commission (EC) approval for anti-seizure drug Ontozry (cenobamate). -
Healthcare industry reported 70 deals worth $6.2 billion in January 2021: GlobalData
February 08, 2021In January 2021, the healthcare industry reported 70 deals worth $6.2 billion as compared to last 12-month average (January 2020 to December 2020) of 87 deals worth $17.1 billion. -
Ovid, Angelini Pharma Enter Exclusive License Agreement
July 14, 2020To develop, manufacture and commercialize OV101 for the treatment of Angelman Syndrome in Europe.
Pharma Sources Insight January 2025
